Dapiprazole
Chemical Properties
| SMILES | Cc1ccccc1N1CCN(CC1)CCc1nnc2n1CCCC2 |
| Hydrogen bond acceptors | 5 |
| Hydrogen bond donors | 0 |
| Rotatable bonds | 4 |
| Molecular weight | 325.2 |
Drug Properties
| Type | Small molecule |
| Endogenous | No |
| Approved | Yes |
| InChIKey | RFWZESUMWJKKRN-UHFFFAOYSA-N |
Database Connections
| External Links |
Bioactivity
| Receptor | Experimental Data | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 8.4 | 8.4 | 8.4 | Guide to Pharmacology |
| α1B | ADA1B | Rat | Adrenoceptors | A | pIC50 | 7.26 | 7.26 | 7.26 | ChEMBL |
| α1B | ADA1B | Rat | Adrenoceptors | A | pKi | 7.52 | 7.52 | 7.52 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pIC50 | 5.94 | 5.94 | 5.94 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 6.28 | 6.28 | 6.28 | ChEMBL |
| α1A | ADA1A | Rat | Adrenoceptors | A | pIC50 | 7.02 | 7.02 | 7.02 | ChEMBL |
| α1A | ADA1A | Rat | Adrenoceptors | A | pKi | 7.41 | 7.41 | 7.41 | ChEMBL |
| α1D | ADA1D | Human | Adrenoceptors | A | pIC50 | 8.08 | 8.08 | 8.08 | ChEMBL |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 8.39 | 8.39 | 8.39 | ChEMBL |
| 5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pIC50 | 5.98 | 5.98 | 5.98 | ChEMBL |
| 5-HT2B | 5HT2B | Human | 5-Hydroxytryptamine | A | pKi | 6.17 | 6.17 | 6.17 | ChEMBL |
| 5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pIC50 | 5.69 | 5.69 | 5.69 | ChEMBL |
| 5-HT1A | 5HT1A | Rat | 5-Hydroxytryptamine | A | pKi | 5.93 | 5.93 | 5.93 | ChEMBL |
| 5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pIC50 | 6.2 | 6.2 | 6.2 | ChEMBL |
| 5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 6.49 | 6.49 | 6.49 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pIC50 | 6.22 | 6.22 | 6.22 | ChEMBL |
| 5-HT2A | 5HT2A | Human | 5-Hydroxytryptamine | A | pKi | 6.76 | 6.76 | 6.76 | ChEMBL |